Abstract
Breast cancers are evolving, multi-scale systems that are characterized by varied complex spatial structures. In this study, we measured the structural characteristics of 33 breast tumours in patients who were to receive neoadjuvant chemotherapy using dynamic contrast enhanced MRI and fractal geometry. The results showed a significant association between fractal measurements and tumour characteristics. The fractal dimension was associated with receptor status (ER and PR) and the fractal fit was associated with response to chemotherapy, measured using a validated pathological response scale, tumour grade and size. This study describes structure measures that may be a consequence of known prognostic factors during the initial and/or maturation phase of tumour growth. These results suggest that measuring tumour structure in this way can predict an individual’s response to neoadjuvant therapy and may identify those who will benefit least from neoadjuvant chemotherapy, allowing alternative treatment options to be selected in those patients.
References
Mandelbrot BB (1983) The Fractal Geometry of Nature. W.H. Freeman, San Francisco
George LE, Sager KH (2007) Breast cancer diagnosis using multi-fractal dimension spectra. IEEE international conference on: signal processing and communications, 2007. ICSPC 2007, Dubai, pp 592–595
Garra BS, Krasner BH, Horii SC et al (1993) Improving the distinction between benign and malignant breast-lesions—the value of sonographic texture analysis. Ultrason Imaging 15:267–285
Byng JW, Boyd NF, Fishell E et al (1996) Automated analysis of mammographic densities. Phys Med Biol 41:909–923
Losa GA, Nonnenmacher TF (1996) Self similarity and fractal irregularity in pathologic tissues. Mod Pathol 9:174–182
Rose CJ, Mills SJ, O’Connor JPB et al (2009) Quantifying spatial heterogeneity in dynamic contrast-enhanced MRI parameter maps. Magn Reson Med 62:488–499
Di Ieva A, Grizzi F, Tschabitscher M et al (2010) Correlation of microvascular fractal dimension with positron emission tomography [(11)C]-methionine uptake in glioblastoma multiforme: preliminary findings. Microvasc Res 80:267–273
Jacquemier JD, Penault-Llorca FM, Bertucci F et al (1998) Angiogenesis as a prognostic marker in breast carcinoma with conventional adjuvant chemotherapy: a multiparametric and immunohistochemical analysis. J Pathol 184:130–135
Tynninen O, Sjostrom J, von Boguslawski K et al (2002) Tumour microvessel density as predictor of chemotherapy response in breast cancer patients. Br J Cancer 86:1905–1908
Semple SIK, Gilbert FJ, Redpath TW et al (2004) The relationship between vascular and metabolic characteristics of primary breast tumours. Eur Radiol 14:2038–2045
Semple SIK, Staff RT, Heys SD et al (2006) Baseline MRI delivery characteristics predict change in invasive ductal breast carcinoma PET metabolism as a result of primary chemotherapy administration. Ann Oncol 17:1393–1398
Tambasco M, Eliasziw M, Magliocco AM (2010) Morphologic complexity of epithelial architecture for predicting invasive breast cancer survival. J Transl Med 8:140
Tofts PS, Berkowitz B, Schnall MD (1995) Quantitative analysis of dynamic Gd-DTPA enhancement in breast tumours using a permeability model. J Magn Reson Med 33:564–568
Brix G, Semmler W, Port R et al (1991) Pharmacokinetic parameters in Cns Gd-Dtpa enhanced MR imaging. J Comput Assist Tomogr 15:621–628
Hayes C, Padhani A, Leach M (2002) Assessing changes in tumour vascular function using dynamic contrast-enhanced magnetic resonance imaging RID C-2248-2008. NMR Biomed 15:154–163
Alic L, Veenland J, van Vliet M et al (2006) Quantification of heterogeneity in dynamic contrast enhanced MRI data for tumor treatment assessment. 2006 3rd IEEE International symposium on biomedical imaging: Macro to Nano, vol 1–3, pp 944–947
Yang X, Knopp MV (2011) Quantifying tumor vascular heterogeneity with dynamic contrast-enhanced magnetic resonance imaging: a review. J Biomed Biotechnol 732848
Mussurakis S, Gibbs P, Horsman A (1998) Primary breast abnormalities: selective pixel sampling on dynamic gadolinium-enhanced MR images. Radiology 206:465–473
Wardlaw G, Wong R, Noseworthy MD (2008) Identification of intratumour low frequency microvascular components via BOLD signal fractal dimension mapping. Physica Med 24:87–91
Barrett T, Brechbiel M, Bernardo M et al (2007) MRI of tumor angiogenesis. J Magn Reson Imaging 26:235–249
Alvarenga AV, Pereira WCA, Infantosi AFC, Azevedo CM (2007) Classifying breast tumours on ultrasound images using a hybrid classifier and texture features. International symposium on intelligent signal processing, 2007. WISP 2007. IEEE, Alcala de Henares, pp 1–6
Risser L, Plouraboue F, Steyer A et al (2007) From homogeneous to fractal normal and tumorous microvascular networks in the brain. J Cereb Blood Flow Metab 27:293–303
O’Connor JPB, Rose CJ, Jackson A et al (2011) DCE-MRI biomarkers of tumour heterogeneity predict CRC liver metastasis shrinkage following bevacizumab and FOLFOX-6. Br J Cancer 105:139–145
Fisher B, Bryant J, Wolmark N et al (1998) Effect of preoperative chemotherapy on the outcome of women with operable breast cancer. J Clin Oncol 16:2672–2685
Smith IC, Heys SD, Hutckeon AW et al (2002) Neoadjuvant chemotherapy in breast cancer: significantly enhanced response with docetaxel. J Clin Oncol 20:1456–1466
Leake R (2000) Detection of the oestrogen receptor (ER): immunohistochemical versus cytosol measurements. Eur J Cancer 36:S18–S19
Paik S, Bryant J, Tan-Chiu E et al (2002) Real-world performance of HER2 testing—national surgical adjuvant breast and bowel project experience. J Natl Cancer Inst 94:852–854
Ogston KN, Miller ID, Payne S et al (2003) A new histological grading system to assess response of breast cancers to primary chemotherapy: prognostic significance and survival. Breast 12:320–327
Hulka B (1996) Epidemiology of susceptibility to breast cancer. Prog Clin Biol Res 395:159–174
Semple S, Gilbert F, Redpath T et al (2003) Correlation of MRI/PET rim enhancement in breast cancer: A delivery related phenomenon with therapy implications? Lancet Oncol 4:759
Acknowledgments
Data acquisition was funded by EPSRC and the Chief Scientist Office (Scotland). Di Giovanni P was funded by Philips Medical Systems; Semple SIK was funded by EPSRC; Gilbert FJ partly funded by the MRC and CRUK.
Conflict of interest
The authors have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Di Giovanni, P., Ahearn, T.S., Semple, S.I.K. et al. The biological correlates of macroscopic breast tumour structure measured using fractal analysis in patients undergoing neoadjuvant chemotherapy. Breast Cancer Res Treat 133, 1199–1206 (2012). https://doi.org/10.1007/s10549-012-2014-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10549-012-2014-8